Back to ACAD
PRINCIPAL FINANCIAL GROUP INC → ACAD
PRINCIPAL FINANCIAL GROUP INC ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
10
Latest value
$17M
Q3 2026
Peak value
$19.7M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $203K |
| Q3 2025 | $14.7M |
| Q4 2025 | $196K |
| Q4 2025 | $19.7M |
| Q1 2026 | $203K |
| Q1 2026 | $16.9M |
| Q2 2026 | $249K |
| Q2 2026 | $19.7M |
| Q3 2026 | $300K |
| Q3 2026 | $17M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $17M | 841.8K | — | — |
| Q3 2026 | $300K | 14.9K | — | — |
| Q2 2026 | $19.7M | 779.3K | — | — |
| Q2 2026 | $249K | 9.9K | — | — |
| Q1 2026 | $16.9M | 759.1K | — | — |
| Q1 2026 | $203K | 9.1K | — | — |
| Q4 2025 | $19.7M | 738.0K | — | — |
| Q4 2025 | $196K | 7.4K | — | — |
| Q3 2025 | $14.7M | 687.1K | — | — |
| Q3 2025 | $203K | 9.5K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M